The Union for International Cancer Control (UICC) has been hosting the World Cancer Congress each year since 1933. This year it was held in Malaysia – the first time in South East Asia.
Thousands of delegates from around the world convened in Kuala Lumpur, “to unite the cancer community, reduce the global cancer burden, promote greater equity and integrate cancer into the world’s health and development agenda.”
The Max Foundation was an active participant:
Side-by-side with other internationally recognized leaders, Pat Garcia-Gonzalez, CEO, shared Max’s 20-year-history in “Uncovering the Stories Behind the Leaders.”
Erin Schwartz, VP of Global Engagement, presented on the importance of including patient perspectives in “Global Equity of Cancer Care.”
Ong Mei Ching, Region Head Asia Pacific, conveyed the importance of patient-centricity in “Best Practice Patient Advocacy in Asia Pacific.”
We attended the World Cancer Congress to raise awareness for our core mission – access to cancer treatment – and how to achieve it through our patient-centered model, Max Access Solutions.
We ran an interactive booth, where attendees made video recordings of their own answers to the question: what does treatment access mean to you?
We have received overwhelming responses from key members of the UICC, counterpart organizations, cancer survivors, advocates, doctors, and healthcare providers.
At this prestigious event – empowered by more than 3,000 leaders, cancer and health experts from 139 countries, and more than 85 years of history – our own Pat Garcia-Gonzalez was honored with the CEO Award. The award was given in recognition of The Max Foundation’s leadership and drive to mobilize people and build partnerships across sectors and borders, transforming a grassroots organization into an international movement impacting the tens of thousands of lives worldwide.
Below are some of the quotes we received:
“Cancer patients in the US, in Europe, in Asia, in Nigeria are the same cancer patients. The only difference is where they live. The advocacy should get through to everyone and the treatment should be affordable to everyone.”
Mr. Runcie C. W. Chidebe, Winner of World Cancer Day Spirit Award of UICC; Executive Director of Project PINK BLUE – Health & Psychological Trust Centre, Nigeria
“I have been following The Max Foundation through the website. Max has done great works in giving support to individuals living with cancer. How do I describe Max in one word? Passionate!”
Dr. Hadi Mohamad Abu Rasheed, Head of Professional Development and Scientific Research of Qatar Cancer Society, Qatar
“The Max Foundation is extraordinary and courageous despite the difficult environment. There are not many organization that can provide such niche supports to cancer communities. I would like to explore the opportunity of collaborating with Max to bring more benefits to cancer patients in Nigera.”
Professor Sani Abubakar Malami, President and CEO of Nigerian Cancer Society, Nigeria
The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.
I have learned that the pain in the heart and soul is deep and will always be there. The ‘bucket’ has a hole, and even when you dedicate every day of your life to making sure other families don’t have to live with this pain, the bucket will never be filled. I have also learned….
Cancerworld recently published an article by Ann Wagstaff titled Begging for imatinib: why do so many patients still lack access to this lifesaver? It highlights the challenges people living with CML face in accessing imatinib, a life-extending medicine that has been generic for many years. Here is our perspective on the story. We have known….
The passing of our dear friend, advocate and colleague Ferdinand, has shaken the close-knit global chronic myeloid leukemia (CML) community. CML, a rare form of leukemia that used to be fatal, now is treated with innovative targeted therapies commonly referred to as TKIs. There has been unprecedented global access to these TKIs and this has fostered the development of one of the strongest global patient communities for a rare cancer. Ferdinand, from Nairobi, Kenya, was a loved member of this community.
